Cited by

• High-dose colistin pharmacokinetics in critically ill patients receiving continuous renal replacement therapy.

  De Pascale G, Lisi L, Cutuli SL, Marinozzi C, Palladini A, Ferrando ES, Tanzarella ES, Lombardi G, Grieco DL, Caroli A, Xhemalaj R, Cascarano L, Ciotti GMP, Sandroni C, Sanguinetti M, Navarra P, Antonelli M. De Pascale G, et al. Ann Intensive Care. 2024 Sep 28;14(1):152. doi: 10.1186/s13613-024-01384-1. Ann Intensive Care. 2024. PMID: 39340688 Free PMC article.
• Early shoulder-girdle MRI findings in severe COVID-19-related intensive care unit-acquired weakness: a prospective cohort study.

  Daste C, Mihoubi F, Roren A, Dumitrache A, Carlier N, Benghanem S, Ruttimann A, Mira JP, Pène F, Roche N, Seror P, Nguyen C, Rannou F, Drapé JL, Lefèvre-Colau MM. Daste C, et al. Eur Radiol. 2023 Jul;33(7):4994-5006. doi: 10.1007/s00330-023-09468-5. Epub 2023 Mar 13. Eur Radiol. 2023. PMID: 36912923 Free PMC article.
• Quadriplegia after ECMO therapy with sluggish recovery in a COVID-19 patient: A case report with a 14-month follow-up.

  Sasano N, Yasuda M, Yamada G. Sasano N, et al. Clin Case Rep. 2022 Dec 13;10(12):e6735. doi: 10.1002/ccr3.6735. eCollection 2022 Dec. Clin Case Rep. 2022. PMID: 36523390 Free PMC article.
• Neurological disorders of COVID-19: insights to applications of natural products from plants and microorganisms.

  Almasi F, Dang W, Mohammadipanah F, Li N. Almasi F, et al. Arch Pharm Res. 2022 Dec;45(12):909-937. doi: 10.1007/s12272-022-01420-3. Epub 2022 Nov 28. Arch Pharm Res. 2022. PMID: 36441470 Free PMC article. Review.
• Intensive care unit-acquired weakness: A review from molecular mechanisms to its impact in COVID-2019.

  Gonzalez A, Abrigo J, Achiardi O, Simon F, Cabello-Verrugio C. Gonzalez A, et al. Eur J Transl Myol. 2022 Aug 26;32(3):10511. doi: 10.4081/ejtm.2022.10511. Eur J Transl Myol. 2022. PMID: 36036350 Free PMC article.